Author:
Maniadakis N.,Kourlaba G.,Shen J.,Holtorf A.
Publisher
Springer Science and Business Media LLC
Reference107 articles.
1. OECD, Pharmaceutical Pricing Policies in a Global Market. Health Policy Studies 2008: p. 1–219.
2. Paris, V., M. Devauc, and L. Wei, Health systems institutional characteristics; A survey of 29 OECD countries. DELSA/HEA/WD/HWP. 1–140. 2010.
3. Kelly RJ, Smith TJ. Delivering maximum clinical benefit at an affordable price: engaging stakeholders in cancer care. Lancet Oncol. 2014;15(3):112–8.
4. Cohen, J.P. and A. Felix, Are payers treating orphan drugs differently? J Mark Access Health Policy, 2014;2:23513.
http://dx.doi.org/10.3402/jmahp.v2.23513
.
5. Howard D, et al. Pricing in the Market for Anticancer Drugs. J Econ Perspect. 2015;29(1):139–62.
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献